Literature DB >> 26210885

Pelvic Organ Prolapse in Female Patients Presenting to Transitional Urology Care Clinic.

Rose Khavari1, Molly Colleen Tokaz2, Julie N Stewart3, Timothy B Boone3.   

Abstract

PURPOSE: Patients with congenital genitourinary abnormalities are growing into adulthood and their expectations, especially in the areas of sexual function and fertility are creating unforeseen challenges for health care providers. We review the incidence and management of pelvic organ prolapse at our Transitional Urology Clinic.
MATERIALS AND METHODS: This study is a retrospective chart review of the presentation and treatment of patients with clinically bothersome pelvic organ prolapse seen at our tertiary Transitional Urology Clinic during 2012 to 2015.
RESULTS: Seven patients with a mean age of 22.8 years presented to our clinic with clinically bothersome prolapse. Four patients had myelomeningocele, 2 had sacral agenesis and 1 had bladder exstrophy. All were on self-catheterization. Three patients were sexually active and 1 had an intact uterus and desired fertility. Bothersome symptoms included vaginal bulge in 6 cases, difficult vaginal intercourse in 1 and difficult catheterization in 1. For the leading edge of Bp (anterior compartment) prolapse the median POP-Q (Pelvic Organ Prolapse Quantification System) stage was 3 (range 1 to 3), for Bp (posterior compartment) prolapse it was 1 (range 0 to 3) and for C (vaginal vault or cervical) prolapse it was 2 (range 1 to 3). Management included pessary in 1 case, hysterectomy with bilateral uterosacral ligament suspension in 4, sacrocolpopexy in 1 and observation in 1. Mean followup was 17.6 months (range 1 to 92). One of the 5 patients treated with surgical intervention had recurrence in the anterior compartment and vaginal vault.
CONCLUSIONS: Females with congenital genitourinary anomalies present with pelvic organ prolapse at a much younger age and a more advanced stage. There is a paucity of literature on the epidemiology, presentation and management of pelvic organ prolapse in this patient population.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  abnormalities; female; pelvic organ prolapse; reconstructive surgical procedures; tertiary healthcare

Mesh:

Year:  2015        PMID: 26210885      PMCID: PMC5485247          DOI: 10.1016/j.juro.2015.07.086

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Adult consequences of spina bifida: a cohort study.

Authors:  James W Roach; Barbara F Short; Hanna M Saltzman
Journal:  Clin Orthop Relat Res       Date:  2011-05       Impact factor: 4.176

Review 3.  Rehabilitation and medical management of the adult with spina bifida.

Authors:  Brad E Dicianno; Brad G Kurowski; Jennifer Marie J Yang; Michael B Chancellor; Ghassan K Bejjani; Andrea D Fairman; Nancy Lewis; Jennifer Sotirake
Journal:  Am J Phys Med Rehabil       Date:  2008-12       Impact factor: 2.159

4.  Living with spina bifida: a historical perspective.

Authors:  Lisa J Pruitt
Journal:  Pediatrics       Date:  2012-07-23       Impact factor: 7.124

5.  Urologic problems in spina bifida patients transitioning to adult care.

Authors:  Stephen J Summers; Sean Elliott; Sean McAdams; Siam Oottamasathien; William O Brant; Angela P Presson; Joseph Fleck; Jeremy West; Jeremy B Myers
Journal:  Urology       Date:  2014-08       Impact factor: 2.649

6.  Sexual activity and vaginal topography in women with symptomatic pelvic floor disorders.

Authors:  Autumn L Edenfield; Pamela J Levin; Alexis A Dieter; Cindy L Amundsen; Nazema Y Siddiqui
Journal:  J Sex Med       Date:  2014-10-08       Impact factor: 3.802

7.  The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care.

Authors:  S E Swift
Journal:  Am J Obstet Gynecol       Date:  2000-08       Impact factor: 8.661

8.  Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery.

Authors:  Jennifer M Wu; Catherine A Matthews; Mitchell M Conover; Virginia Pate; Michele Jonsson Funk
Journal:  Obstet Gynecol       Date:  2014-06       Impact factor: 7.661

Review 9.  Complex gynaecological and urological problems in adolescents: challenges and transition.

Authors:  Sarah M Creighton; Dan Wood
Journal:  Postgrad Med J       Date:  2012-10-05       Impact factor: 2.401

10.  Adolescent urology: A challenge for adult urologists.

Authors:  C R J Woodhouse
Journal:  Indian J Urol       Date:  2007-10
View more
  4 in total

1.  FPMRS challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium (CoRPS): managing complicated cases : Series 3: Challenging recurrent prolapse in a medically complicated patient.

Authors:  Danielle D Antosh; Ladin A Yurteri-Kaplan; David Shveiky; Madalena Liu; Chris Heisler; Aparna Hegde; Cara L Grimes
Journal:  Int Urogynecol J       Date:  2019-04-29       Impact factor: 2.894

2.  Fertility and sexuality issues in congenital lifelong urology patients: female aspects.

Authors:  Gunter De Win; Stéphanie Dautricourt; Rebecca Deans; Rizwan Hamid; Moneer K Hanna; Rose Khavari; Rosalia Misseri; Margaret G Mueller; Joshua Roth; Anne-Françoise Spinoit
Journal:  World J Urol       Date:  2020-09-28       Impact factor: 4.226

Review 3.  Contemporary management considerations of urinary tract infections for women with spina bifida.

Authors:  Ellen Fremion; Paola Bustillos; Rose Khavari
Journal:  Int Urogynecol J       Date:  2021-06-03       Impact factor: 2.894

Review 4.  Sexual Function of Men and Women With Spina Bifida: A Scoping Literature Review.

Authors:  Courtney S Streur; Lauren Corona; Judith E Smith; Muzi Lin; John S Wiener; Daniela A Wittmann
Journal:  Sex Med Rev       Date:  2021-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.